Michael Kersten
Impact in
-
- Immunotherapy and Immune Responses
Papers in
-
- RNA modifications and cancer 2
-
- Ferroptosis and cancer prognosis 2
- Renal cell carcinoma treatment 2
- Co-authors
- Alois Harder (5 shared papers)Florry A. Vyth‐Dreese (3 shared papers)Johan Sein (3 shared papers)W J Nooijen (3 shared papers)F. Lottspeich (2 shared papers)Johannes Beckers (2 shared papers)Martin Hrabě de Angelis (2 shared papers)Clay Routledge (2 shared papers)
- Journals
- PROTEOMICS (3 papers)British Journal of Cancer (2 papers)The Journal of Social Psychology (1 paper)Molecular & Cellular Proteomics (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- GermanyNetherlandsUnited States
In The Last Decade
Michael Kersten
12 papers receiving 375 citations
Peers
Comparison fields: 5 of 91
- Immunology 64
- Cancer Research 43
- Small Animals 21
- Oncology 70
- Spectroscopy 40
Countries citing papers authored by Michael Kersten
This map shows the geographic impact of Michael Kersten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kersten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kersten more than expected).
Fields of papers citing papers by Michael Kersten
This network shows the impact of papers produced by Michael Kersten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kersten. The network helps show where Michael Kersten may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Kersten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 73 | |
| 2 | Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. | 2000 | 47 |
| 3 | 2003 | 39 | |
| 4 | 2005 | 36 | |
| 5 | 2003 | 36 | |
| 6 | 2017 | 33 | |
| 7 | 2003 | 30 | |
| 8 | 2009 | 27 | |
| 9 | 2009 | 24 | |
| 10 | 2005 | 20 | |
| 11 | 2016 | 17 | |
| 12 | 2020 | 6 | |
| 13 | Protein isoforms in cancer, identified and quantified by the ICPL (isotope-coded protein labelling) technology | 2006 | 1 |
About Michael Kersten
Michael Kersten is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Immunology and Social Psychology, having authored 13 papers that have together received 389 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Death Anxiety and Social Exclusion (2 papers), Ferroptosis and cancer prognosis (2 papers), Advanced Proteomics Techniques and Applications (2 papers), Renal cell carcinoma treatment (2 papers), RNA modifications and cancer (2 papers) and Psychological Well-being and Life Satisfaction (1 paper). The work is most often cited by research in Immunology (64 citations), Cancer Research (43 citations), Small Animals (21 citations), Oncology (70 citations) and Spectroscopy (40 citations). Michael Kersten has collaborated with scholars based in Germany, Netherlands and United States. Frequent co-authors include Alois Harder, Florry A. Vyth‐Dreese, Johan Sein, W J Nooijen, F. Lottspeich, Johannes Beckers, Martin Hrabě de Angelis, Clay Routledge, Cathy R. Cox and Marion Horsch. Their work appears in journals such as PROTEOMICS, British Journal of Cancer, The Journal of Social Psychology, Molecular & Cellular Proteomics and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.